Logo
SearchSearch
Languages
Language
LoginSign up
Stocks-SLN-Silence Therapeutics Plc

Silence Therapeutics Plc SLN

3.50.19(5.72%)(1D)
Delayed prices by Nasdaqin USD
Invest in Silence Therapeutics Plc
Today
Create an eToro account to buy SLN stock on a secure, user-friendly, multi-asset trading platform.
Buy Silence Therapeutics Plc
Buy Silence Therapeutics Plc
Silence Therapeutics Plc SLN

SLN Stock Price Chart

‎0.86‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Silence Therapeutics Plc share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Silence Therapeutics Plc share price today is 3.5, reflecting a ‎5.72‎% change over the last 24 hours and ‎12.14‎% over the past week. The current market capitalization of SLN is 165.76M with an average volume in the last three months of 273018.68. The stock has a P/E ratio of -2.1 and a dividend yield of 0%. With the stock’s beta sitting at 0.74
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
165.76M

Day’s Range
i
Shows the high and low prices of the day.
1.96 - 3.5

52W Range
i
Shows the high and low prices of the last year.
1.96 - 27.48

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
273018.68

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-2.1

Revenue
i
The total income generated by this company’s goods and services last year.
20.57M

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)

Prev Close
i
The final price of this asset at the end of the last trading day.
3.51

EPS
i
A company’s total earnings divided by the number of shares it has issued.
-1.67

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.74

How can I buy Silence Therapeutics Plc stocks?

To purchase Silence Therapeutics Plc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Silence Therapeutics Plc (SLN) page and place an order to buy Silence Therapeutics Plc.
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Graph
Buy Silence Therapeutics Plc
Invest in Silence Therapeutics Plc
Today
Create an eToro account to buy SLN stock on a secure, user-friendly, multi-asset trading platform.

FAQ

The current price of SLN is 3.5.
The average price target for Silence Therapeutics Plc is 3.5. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Silence Therapeutics Plc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Silence Therapeutics Plc is 165.76M
Based on analysts offering recommendations for SLN in the last 3 months, the overall consensus is .
Scroll to top